| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.0081 | 0.9 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.028 | 0.9 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |